MedTrace Logo

Liposomal Bupivacaine in Total Shoulder Arthroplasty

NCT02570022 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2016-10-13

Study results available
· View outcomes & findings →

Summary

This is a randomized, single blinded, standard of care controlled clinical trial. All adult patients over eighteen desiring shoulder arthroplasty will be eligible. The study compares pain control and opioid consumption in patients undergoing shoulder arthroplasty between patients receiving liposomal bupivacaine and those who underwent a preoperative inter-scalene nerve block.

Conditions

Interventions

DRUG

Liposomal bupivacaine

Local infiltration of liposomal bupivacaine

PROCEDURE

Inter-scalene nerve block

Pre-operative inter-scalene nerve block

DRUG

Ropivacaine

Ropivicaine was used for the inter-scalene nerve block.

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-05-31
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02570022 on ClinicalTrials.gov